News and Announcements
Read the latest news from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. The links below take you to articles where you can learn more about our center's latest events and accomplishments. You can also visit the article archive for older news.
A combination of three therapies was found to provide the greatest benefit to patients with metastatic breast cancer classified as HER2- and hormone receptor-positive, who aren't candidates for chemotherapy, according to a Northwestern Medicine clinical trial.
Results of a randomized controlled trial suggest that systematic bright light exposure can improve sleep for fatigued people who have been treated for cancer.
Congratulations to the many Robert H. Lurie Comprehensive Cancer Center of Northwestern University specialists who were named to the 2018 Chicago magazine list of “Top Doctors.”
A new Northwestern Medicine study detailed a technique that could help scientists find the cause of cancer or autism-spectrum disease stemming from faulty protein disposal.
- Malnati Brain Tumor Institute of the Lurie Cancer Center at Northwestern Memorial Hospital Congratulates Physicians Named as ‘Top Doctors’ by Chicago Magazine01.08.2018
Congratulations to our Malnati Brain Tumor Institute of the Lurie Cancer Center at Northwestern Memorial Hospital team members who were named to the 2018 Chicago Magazine list of Top Doctors.
A pathbreaking series of compounds designed and synthesized at Northwestern’s Center for Molecular Innovation and Drug Discovery (CMIDD) has been shown to starve multiple myeloma — a rare form of blood cancer — of its favorite food.
Lurie Cancer Center’s Deputy Director describes how Chicago’s brain trust, diversity, and culture of philanthropy impact her research and patient care.
What’s the latest information about MPN treatment and research? As part of our ASH 2017 coverage, Dr. John Crispino and Dr. Angela Fleischman, Joined Patient Power to share what they learned at this year’s annual meeting in Atlanta.
For our partners at The H Foundation, 2017 was a record-breaking year of fundraising to support research at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
A device attached to a patient’s scalp that delivers a continuous dose of low-intensity electric fields improves survival and slows the growth of a deadly brain tumor, according to a new trial.
Joshua Rappoport, PhD, serves as director of the Center for Advanced Microscopy and Nikon Imaging Center at Feinberg. The center supports research across the University through expertise, training and access to state-of-the-art imaging instruments. The facility’s services include electron microscopy, as well as light microscopy, and both fluorescent and bioluminescent animal imaging. Rappoport, also a research professor of Cell and Molecular Biology, is a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
Even as those around you wrap gifts, bake cookies and deck the halls, cancer can make it difficult to “get in the spirit.” Worse, it can be an especially lonely and uncertain place as we move through the holidays and into a new year.
Holidays are traditionally viewed as a time to celebrate. However, sometimes people with cancer and their loved ones feel “out of step” from the rest of the world during the holidays.
Faculty members in Northwestern’s Department of Dermatology are working hard to better understand the fundamentals of skin biology and to bring those discoveries to the forefront of skin treatment. Their research extends from deciphering the genetic and molecular basis of deadly skin cancers, to trying to avoid harmful side effects of treatments like glucocorticoids, to preventing disease-related complications like neuropathy.
Associate director of clinical informatics in Lurie Cancer Center’s Quantitative Data Sciences Core named to newly created role.
A Northwestern Medicine study, published in the journal Cancer Cell, has provided new insights into a mechanism of tumor survival in glioblastoma and demonstrated that inhibiting the process could enhance the effects of radiation therapy.
Diagnosed with Stage IV lung cancer in October 2016, Chuck Maniscalco speaks about coping with cancer in this video presentation.
- ASCO’s Conquer Cancer Foundation highlights Leonidas Platanias, MD, PhD, and the city that inspires his efforts12.04.2017
An interview with Leonidas Platanias, MD, PhD, by the Conquer Cancer Foundation of ASCO.
Newly diagnosed with malignant glioblastoma, Harold “Woody” Wolff was looking for his best chance at beating this aggressive and deadliest of brain cancers. He received that chance — and much more — after seeking a second opinion from James Chandler, MD, ’96 GME, the Lavin/Fates Professor of Neurological Surgery and co-director of the Lou and Jean Malnati Brain Tumor Institute at Northwestern Medicine.
Scientists reduced blood clotting in mice with a blood disease called myeloproliferative neoplasm by inhibiting expression of a gene.
See more news in the article archive.